HDP-101, an anti-BCMA antibody-drug conjugate, safely delivers amanitin to induce cell death in proliferating and resting multiple myeloma cells
Despite major treatment advances in recent years, patients with multiple myeloma inevitably relapse. The RNA polymerase II complex has been identified as a promising therapeutic target in both proliferating and dormant cancer cells. Alpha-amanitin, a toxin so far without clinical application due to...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2021
|
| In: |
Molecular cancer therapeutics
Year: 2021, Jahrgang: 20, Heft: 2, Pages: 367-378 |
| ISSN: | 1538-8514 |
| DOI: | 10.1158/1535-7163.MCT-20-0287 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/1535-7163.MCT-20-0287 Verlag, lizenzpflichtig, Volltext: https://mct.aacrjournals.org/content/20/2/367 
|
| Verfasserangaben: | Vianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig, Anja Baumann, Nicola Giesen, Anikó Pálfi, Christoph Müller, Christian Lutz, Torsten Hechler, Michael Kulke, Carsten Müller-Tidow, Alwin Krämer, Hartmut Goldschmidt, Andreas Pahl, and Marc S. Raab |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1753173795 | ||
| 003 | DE-627 | ||
| 005 | 20230426165442.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210406s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1158/1535-7163.MCT-20-0287 |2 doi | |
| 035 | |a (DE-627)1753173795 | ||
| 035 | |a (DE-599)KXP1753173795 | ||
| 035 | |a (OCoLC)1341403280 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Figueroa Vazquez, Vianihuini |e VerfasserIn |0 (DE-588)1144392187 |0 (DE-627)1004717652 |0 (DE-576)495366331 |4 aut | |
| 245 | 1 | 0 | |a HDP-101, an anti-BCMA antibody-drug conjugate, safely delivers amanitin to induce cell death in proliferating and resting multiple myeloma cells |c Vianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig, Anja Baumann, Nicola Giesen, Anikó Pálfi, Christoph Müller, Christian Lutz, Torsten Hechler, Michael Kulke, Carsten Müller-Tidow, Alwin Krämer, Hartmut Goldschmidt, Andreas Pahl, and Marc S. Raab |
| 246 | 3 | 0 | |a one hundred and one |
| 264 | 1 | |c 2021 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online first: December 9, 2020 | ||
| 500 | |a Gesehen am 08.09.2021 | ||
| 520 | |a Despite major treatment advances in recent years, patients with multiple myeloma inevitably relapse. The RNA polymerase II complex has been identified as a promising therapeutic target in both proliferating and dormant cancer cells. Alpha-amanitin, a toxin so far without clinical application due to high liver toxicity, specifically inhibits this complex. Here, we describe the development of HDP-101, an anti-B-cell maturation antigen (BCMA) antibody conjugated with an amanitin derivative. HDP-101 displayed high efficacy against both proliferating and resting myeloma cells in vitro, sparing BCMA-negative cells. In subcutaneous and disseminated murine xenograft models, HDP-101 induced tumor regression at low doses, including durable complete remissions after a single intravenous dose. In cynomolgus monkeys, HDP-101 was well tolerated with a promising therapeutic index. In conclusion, HDP-101 safely and selectively delivers amanitin to myeloma cells and provides a novel therapeutic approach to overcome drug resistance in this disease. | ||
| 700 | 1 | |a Ko, Jonathan |d 1993- |e VerfasserIn |0 (DE-588)1257103237 |0 (DE-627)180120182X |4 aut | |
| 700 | 1 | |a Breunig, Christian |e VerfasserIn |0 (DE-588)1079423249 |0 (DE-627)840973764 |0 (DE-576)452457858 |4 aut | |
| 700 | 1 | |a Baumann, Anja |e VerfasserIn |0 (DE-588)1240798776 |0 (DE-627)1769711376 |4 aut | |
| 700 | 1 | |a Giesen, Nicola |d 1983- |e VerfasserIn |0 (DE-588)141844272 |0 (DE-627)631828524 |0 (DE-576)32643657X |4 aut | |
| 700 | 1 | |a Palfi, Aniko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Müller, Christoph |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lutz, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hechler, Torsten |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kulke, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Krämer, Alwin |e VerfasserIn |0 (DE-588)1067780025 |0 (DE-627)819183431 |0 (DE-576)426900820 |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Pahl, Andreas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Raab, Marc-Steffen |d 1973- |e VerfasserIn |0 (DE-588)124052460 |0 (DE-627)706520998 |0 (DE-576)293998027 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular cancer therapeutics |d Philadelphia, Pa. : AACR, 2001 |g 20(2021), 2, Seite 367-378 |h Online-Ressource |w (DE-627)336800576 |w (DE-600)2062135-8 |w (DE-576)098253522 |x 1538-8514 |7 nnas |a HDP-101, an anti-BCMA antibody-drug conjugate, safely delivers amanitin to induce cell death in proliferating and resting multiple myeloma cells |
| 773 | 1 | 8 | |g volume:20 |g year:2021 |g number:2 |g pages:367-378 |g extent:13 |a HDP-101, an anti-BCMA antibody-drug conjugate, safely delivers amanitin to induce cell death in proliferating and resting multiple myeloma cells |
| 856 | 4 | 0 | |u https://doi.org/10.1158/1535-7163.MCT-20-0287 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://mct.aacrjournals.org/content/20/2/367 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210406 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 124052460 |a Raab, Marc-Steffen |m 124052460:Raab, Marc-Steffen |d 910000 |d 910100 |e 910000PR124052460 |e 910100PR124052460 |k 0/910000/ |k 1/910000/910100/ |p 15 |y j | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |e 910000PG102258023X |e 910100PG102258023X |k 0/910000/ |k 1/910000/910100/ |p 13 | ||
| 998 | |g 1067780025 |a Krämer, Alwin |m 1067780025:Krämer, Alwin |d 910000 |d 910100 |e 910000PK1067780025 |e 910100PK1067780025 |k 0/910000/ |k 1/910000/910100/ |p 12 | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ |p 11 | ||
| 998 | |g 141844272 |a Giesen, Nicola |m 141844272:Giesen, Nicola |d 910000 |d 910100 |e 910000PG141844272 |e 910100PG141844272 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 1079423249 |a Breunig, Christian |m 1079423249:Breunig, Christian |d 50000 |e 50000PB1079423249 |k 0/50000/ |p 3 | ||
| 998 | |g 1257103237 |a Ko, Jonathan |m 1257103237:Ko, Jonathan |d 50000 |e 50000PK1257103237 |k 0/50000/ |p 2 | ||
| 998 | |g 1144392187 |a Figueroa Vazquez, Vianihuini |m 1144392187:Figueroa Vazquez, Vianihuini |p 1 |x j | ||
| 999 | |a KXP-PPN1753173795 |e 3902156619 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1753173795"],"doi":["10.1158/1535-7163.MCT-20-0287"]},"name":{"displayForm":["Vianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig, Anja Baumann, Nicola Giesen, Anikó Pálfi, Christoph Müller, Christian Lutz, Torsten Hechler, Michael Kulke, Carsten Müller-Tidow, Alwin Krämer, Hartmut Goldschmidt, Andreas Pahl, and Marc S. Raab"]},"recId":"1753173795","physDesc":[{"extent":"13 S."}],"title":[{"title":"HDP-101, an anti-BCMA antibody-drug conjugate, safely delivers amanitin to induce cell death in proliferating and resting multiple myeloma cells","title_sort":"HDP-101, an anti-BCMA antibody-drug conjugate, safely delivers amanitin to induce cell death in proliferating and resting multiple myeloma cells"}],"note":["Published online first: December 9, 2020","Gesehen am 08.09.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"family":"Figueroa Vazquez","given":"Vianihuini","role":"aut","display":"Figueroa Vazquez, Vianihuini"},{"display":"Ko, Jonathan","family":"Ko","role":"aut","given":"Jonathan"},{"role":"aut","given":"Christian","family":"Breunig","display":"Breunig, Christian"},{"display":"Baumann, Anja","role":"aut","given":"Anja","family":"Baumann"},{"family":"Giesen","given":"Nicola","role":"aut","display":"Giesen, Nicola"},{"display":"Palfi, Aniko","role":"aut","given":"Aniko","family":"Palfi"},{"family":"Müller","role":"aut","given":"Christoph","display":"Müller, Christoph"},{"display":"Lutz, Christian","family":"Lutz","role":"aut","given":"Christian"},{"display":"Hechler, Torsten","role":"aut","given":"Torsten","family":"Hechler"},{"role":"aut","given":"Michael","family":"Kulke","display":"Kulke, Michael"},{"display":"Müller-Tidow, Carsten","family":"Müller-Tidow","given":"Carsten","role":"aut"},{"display":"Krämer, Alwin","given":"Alwin","role":"aut","family":"Krämer"},{"family":"Goldschmidt","given":"Hartmut","role":"aut","display":"Goldschmidt, Hartmut"},{"display":"Pahl, Andreas","given":"Andreas","role":"aut","family":"Pahl"},{"given":"Marc-Steffen","role":"aut","family":"Raab","display":"Raab, Marc-Steffen"}],"relHost":[{"corporate":[{"display":"American Association for Cancer Research","role":"isb"}],"name":{"displayForm":["American Association for Cancer Research"]},"pubHistory":["1.2001/02 -"],"id":{"zdb":["2062135-8"],"eki":["336800576"],"issn":["1538-8514"]},"part":{"year":"2021","volume":"20","pages":"367-378","issue":"2","text":"20(2021), 2, Seite 367-378","extent":"13"},"origin":[{"publisherPlace":"Philadelphia, Pa.","dateIssuedKey":"2001","dateIssuedDisp":"2001-","publisher":"AACR"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 25.02.25","Fortsetzung der Druck-Ausgabe"],"title":[{"title_sort":"Molecular cancer therapeutics","title":"Molecular cancer therapeutics"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"336800576","disp":"HDP-101, an anti-BCMA antibody-drug conjugate, safely delivers amanitin to induce cell death in proliferating and resting multiple myeloma cellsMolecular cancer therapeutics"}],"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}]} | ||
| SRT | |a FIGUEROAVAHDP101ANAN2021 | ||